Share on StockTwits
 

Analysts’ downgrades for Wednesday, January 1st:

New Oriental Education & Tech. Group (NYSE:EDU) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. Zacks currently has $33.00 price target on the stock.

Enanta Pharmaceuticals (NASDAQ:ENTA) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $33.30 target price on the stock.

Esterline Technologies Corp. (NYSE:ESL) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. They currently have $100.00 price target on the stock.

Elbit Systems (NASDAQ:ESLT) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $63.30 price target on the stock.

Comfort Systems USA (NYSE:FIX) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $22.20 price target on the stock.

H&E Equipment Services (NASDAQ:HEES) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. The firm currently has $32.40 target price on the stock.

Kemet Corp. (NYSE:KEM) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. Zacks currently has $6.60 price target on the stock.

Lionbridge Technologies (NASDAQ:LIOX) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $6.80 price target on the stock.

Ocera Therapeutics (NASDAQ:OCRX) was downgraded by analysts at Zacks to a neutral rating. Zacks currently has $13.60 price target on the stock.

TIM Participacoes SA (NYSE:TSU) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. They currently have $24.90 price target on the stock.

Vitran (NASDAQ:VTNC) was downgraded by analysts at TD Securities from a hold rating to a tender rating. TD Securities currently has C$6.50 price target on the stock, up from their previous price target of C$6.00.

Western Alliance Bancorp. (NYSE:WAL) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $25.70 target price on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.